Home Newsfeeds BTIG Downgrades Applied Genetic to Neutral

BTIG Downgrades Applied Genetic to Neutral

BTIG analyst Yun Zhong downgrades Applied Genetic (NASDAQ:AGTC) from Buy to Neutral.

byBenzinga Newsdesk

September 29, 2022

1 minute read

BTIG analyst Yun Zhong downgrades Applied Genetic (NASDAQ:AGTC) from Buy to Neutral.

‘U.S. Holiday Spending During November And December Expected To Grow Between 3% And 4% Over 2022 To Between $957.3B And $966.6B’ – NRF

By Benzinga Newsdesk

November 2, 11:22 AM

https://nrf.com/media-center/press-releases/2023-holiday-reach-record-spending-levelsThe National Retail Federation today forecast that holiday spending is expected to reach record levels during November and December and

KSS

Nu Skin Enterprises Q4 EPS $0.89 Beats $0.53 Estimate, Sales $522.34M Miss $542.32M Estimate

By Benzinga Newsdesk

February 15, 5:08 PM

Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.89 per share which beat the analyst consensus estimate of $0.53 by 67.92 percent. This is a 19.82 percent decrease over earnings of $1.11 per share from

NUS

Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

September 15, 1:03 PM

Gainers HeartBeam, Inc. (NASDAQ: BEAT) shares surged 58% to $1.96 after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO.

ADBE